Diabetic Kidney Disease in Post-Kidney Transplant Patients

被引：1
|
作者：
Pham, Ngoc-Yen T. [1 ]
Cruz, Diego [2 ]
Madera-Marin, Luis [1 ]
Ravender, Raja [1 ]
Garcia, Pablo [1 ]
机构：
[1] Univ New Mexico, Sch Med, Div Nephrol, Albuquerque, NM 87106 USA
[2] Hosp Gen San Juan Dios, Guatemala City 01001, Guatemala
来源：
JOURNAL OF CLINICAL MEDICINE | 2024年 / 13卷 / 03期
关键词：
PTDM; kidney transplant; diabetic nephropathy; diabetes; BASAL INSULIN THERAPY; LONG-TERM; RENAL-TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; CARDIOVASCULAR OUTCOMES; GLUCOSE-METABOLISM; RAPAMYCIN TOXICITY; MTOR INHIBITION; UNITED-STATES; DOUBLE-BLIND;
D O I：
10.3390/jcm13030793
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Post-transplant diabetes mellitus (PTDM) is a common occurrence in post-kidney transplantation and is associated with greater mortality, allograft failure, and increased risk of infections. The primary goal in the management of PTDM is to achieve glycemic control to minimize the risk of complications while balancing the need for immunosuppression to maintain the health of the transplanted kidney. This review summarizes the effects of maintenance immunosuppression and therapeutic options among kidney transplant recipients. Patients with PTDM are at increased risk of diabetic kidney disease development; therefore, in this review, we focus on evidence supporting the use of novel antidiabetic agents and discuss their benefits and potential side effects in detail.
引用
收藏
页数：18
相关论文
共 50 条
  • [1] Nephrotic Syndrome Post-Kidney Transplant
    Hennigar, Randolph A.
    Klein, Christina L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (08): : 1347 - 1350
  • [2] Hepatic Dysfunction Post-Kidney Transplant
    Rogers, Michael E.
    Balistreri, William F.
    JOURNAL OF PEDIATRICS, 2022, 247 : 137 - 137
  • [3] Outcomes of Post-Kidney Transplant Leukemias
    Rouphael, B.
    Kukla, A.
    Gillingham, K.
    Ibrahim, H.
    Matas, A.
    Issa, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [4] Vaccination for the post-kidney transplant population
    Jain, Shilpa R.
    Kumar, Deepali
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06): : 581 - 586
  • [5] INCIDENCE OF POST-KIDNEY TRANSPLANT ERYTHROCYTOSIS AT THE NATIONAL KIDNEY AND TRANSPLANT INSTITUTE
    Rae Nicolasora, Annia
    Casasola, Concesa
    Pile-Coronel, Marichel
    TRANSPLANT INTERNATIONAL, 2019, 32 : 241 - 241
  • [6] Vasopressin for Post-kidney Transplant Hypotension
    Jan, Muhammad Y.
    Moe, Sharon M.
    Adebiyi, Oluwafisayo
    Chen, Jeannie
    Powelson, John
    Burney, Heather N.
    Yaqub, Muhammad S.
    Mishler, Dennis P.
    Moorthi, Ranjani N.
    Taber, Tim E.
    Anderson, Melissa D.
    Li, Yang
    Li, Xiaochun
    Fridell, Jonathan A.
    Goggins, William C.
    Sharfuddin, Asif A.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (06): : 1364 - 1376
  • [7] Angiogenic Activity in the Sera of Patients with Post-Kidney Transplant Erythrocytosis
    Maktouf, Chokri
    Yaich, Soumaya
    Aloui, Sabra
    Bounemra, Azza
    Charfeddine, Khaled
    Skhiri, Habib
    Hachicha, Jamil
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2014, 25 (05) : 1026 - 1029
  • [8] Therapeutic management of post-kidney transplant hyperparathyroidism
    Copley, John B.
    Wuethrich, Rudolf P.
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : 24 - 39
  • [9] Surveillance biopsies in children post-kidney transplant
    Birk, Patricia E.
    PEDIATRIC NEPHROLOGY, 2012, 27 (05) : 753 - 760
  • [10] Surveillance biopsies in children post-kidney transplant
    Patricia E. Birk
    Pediatric Nephrology, 2012, 27 : 753 - 760
12345